ROLE OF PROTEASE INHIBITION IN MYOCARDIAL PRESERVATION FOLLOWING ISCHEMIA AND REPERFUSION

被引：0

作者：

GUREVITCH, J ^{[1
]}

PAZ, Y ^{[1
]}

BARAK, J ^{[1
]}

MATSA, M ^{[1
]}

KRAMER, A ^{[1
]}

PEVNI, D ^{[1
]}

HOCHHAUSER, E ^{[1
]}

YAKIREVICH, V ^{[1
]}

机构：

[1] ICHILOV HOSP,DEPT THORAC & CARDIOVASC SURG,IL-64239 TEL AVIV,ISRAEL

来源：

JOURNAL OF CARDIOVASCULAR SURGERY | 1994年 / 35卷 / 06期

关键词：

APROTININ; MYOCARDIAL REPERFUSION; ISCHEMIA;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Aprotinin, a naturally occurring protease inhibitor, in concentrations of 10(6) KIU/L was found to have no effect on myocardial performance in normally perfused isolated rat hearts, before ischemia. Given during the preischemic period, the drug had a significant protective effect on the reperfused hearts, following cardioplegic ischemia: better contractility upon reperfusion (p < 0.011), faster decline of the ischemic contracture, higher coronary flow (p < 0,025), lower AV-difference (p < 0.05), and lower CPK levels (p < 0.01).

引用

页码：95 / 98

页数：4

共 50 条

[31] Differential protease inhibition confirms the role of mouse mast cell protease (mMCP) 5 in ischemia/reperfusion (IR) injury of muscle
Shi, Tong
Xu, Yuhui
Abrink, Magnus
Pejlar, Gunnar
Moore, Francis Daniels, Jr.
Stevens, Richard I.
Gurish, Michael F.
JOURNAL OF IMMUNOLOGY, 2006, 176 : S212 - S212
[32] Aprotinin and preservation of myocardial function after ischemia-reperfusion injury
Bull, DA
Maurer, J
ANNALS OF THORACIC SURGERY, 2003, 75 (02): : S735 - S739
[33] COMPLEMENT ACTIVATION AND INHIBITION IN MYOCARDIAL-ISCHEMIA AND REPERFUSION INJURY
HOMEISTER, JW
LUCCHESI, BR
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 : 17 - 40
[34] Ras inhibition attenuates myocardial ischemia-reperfusion injury
Pando, Rakefet
Cheporko, Yelena
Haklai, Ronit
Maysel-Auslender, Sofia
Keren, Gad
George, Jacob
Porat, Eyal
Sagie, Alex
Kloog, Yoel
Hochhauser, Edith
BIOCHEMICAL PHARMACOLOGY, 2009, 77 (10) : 1593 - 1601
[35] Selectin inhibition preserves myocardial blood flow and left ventricular function following ischemia and prolonged reperfusion
Flynn, DM
Buda, AJ
Jeffords, PR
Vo, KD
Lefer, DJ
JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A26 - A26
[36] The role of microRNAs in regulating myocardial ischemia reperfusion injury
Fan, Zhi-Xing
Yang, Jian
SAUDI MEDICAL JOURNAL, 2015, 36 (07) : 787 - 793
[37] Inhibition of TNF-α reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog
Gu, Qiuping
Yang, Xiao Ping
Bonde, Pramod
DiPaula, Anthony
Fox-Talbot, Karen
Becker, Lewis C.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 48 (06) : 320 - 328
[38] HDAC inhibition as a therapeutic strategy in myocardial ischemia/reperfusion injury
Xie, Min
Tang, Yida
Hill, Joseph A.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 129 : 188 - 192
[39] Evolving role of the mast cell in myocardial ischemia and reperfusion
Frangogiannis, NG
Perrard, JL
Mendoza, LH
Youker, KA
Lindsey, ML
Ballantyne, CM
Michael, LH
Smith, CW
Entman, ML
CORONARY MICROCIRCULATION DURING ISCHAEMIA AND REPERFUSION, 1997, 41 : 278 - 293
[40] REFLEX RESPONSES TO MYOCARDIAL ISCHEMIA AND REPERFUSION - ROLE OF PROSTAGLANDINS
THAMES, MD
MINISI, AJ
CIRCULATION, 1989, 80 (06) : 1878 - 1885

← 1 2 3 4 5 →